Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for A1RS43

Entry ID Method Resolution Chain Position Source
AF-A1RS43-F1 Predicted AlphaFoldDB

No variants for A1RS43

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for A1RS43

No associated diseases with A1RS43

1 regional properties for A1RS43

Type Name Position InterPro Accession
domain Luciferase-like domain 5 - 325 IPR011251

Functions

Description
EC Number 3.6.5.4 Acting on GTP; involved in cellular and subcellular movement
Subcellular Localization
  • Cytoplasm
  • The SRP-RNC complex is targeted to the cytoplasmic membrane
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
signal recognition particle A complex of protein and RNA which facilitates translocation of proteins across membranes.

3 GO annotations of molecular function

Name Definition
7S RNA binding Binding to a 7S RNA, the RNA component of the signal recognition particle (SRP).
GTP binding Binding to GTP, guanosine triphosphate.
GTPase activity Catalysis of the reaction: GTP + H2O = GDP + H+ + phosphate.

1 GO annotations of biological process

Name Definition
SRP-dependent cotranslational protein targeting to membrane The targeting of proteins to a membrane that occurs during translation and is dependent upon two key components, the signal-recognition particle (SRP) and the SRP receptor. SRP is a cytosolic particle that transiently binds to the endoplasmic reticulum (ER) signal sequence in a nascent protein, to the large ribosomal unit, and to the SRP receptor in the ER membrane.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MKALGEVFSK LVEKIRGVSY IDEATLQELS REIQRALLKA DVPLDMVKTF TENAVKRMRE
70 80 90 100 110 120
EKPPAGIPPR EYVLYILYDE LVKLLGGEQP AEFKPVKKPY LVLLLGVEGS GKTTTAAKLA
130 140 150 160 170 180
RYLVKRGYRV GLVETDTIRP AAFDQLKQLA EKIGVPFYGE RDSKDAVEIA RRGVQNFKNM
190 200 210 220 230 240
DVVIIDTAGR HKNEEALLQE VKMIYEAVNP DEVILVIDAT VGKLAAAQAE AFMKYLPIHS
250 260 270 280 290 300
VIITKMDSTA RGGGALAAVI KTGARVKFIG VGEDVDEFDL FNPRKFVARV LGMGDLDALV
310 320 330 340 350 360
EKIKAVFEEE KVLQEIESGR LDLLTFKKQI EGLLKLGPLS KVLQLLPGGF AAKISEEQVE
370 380 390 400 410 420
LSQKNLKKWY AILSSMTIEE LKNPDILNAS RIRRIALGAG VTPKDVKEML TVYENLKKMS
430
KTLKRQLRMR IPK